Fluconazole is classified as a hazardous drug by the National Institute for Occupational Safety and Health (NIOSH), which surprises many people because it’s one of the most commonly prescribed antifungal medications. The “hazardous” label doesn’t mean the drug is too dangerous to take. It means fluconazole poses specific risks to patients and to healthcare workers who handle it repeatedly without protection. Those risks span several categories: liver toxicity, heart rhythm disruption, birth defects, dangerous drug interactions, and rare but severe skin reactions.
Why NIOSH Lists It as Hazardous
NIOSH maintains an official list of hazardous drugs in healthcare settings, updated most recently in 2024. Fluconazole appears in Table 2 of that list. To land there, a drug must meet at least one of several toxicity criteria: it causes cancer, damages developing fetuses, harms reproductive systems, damages DNA, or injures organs at low doses. Fluconazole qualifies primarily because of its developmental toxicity, meaning its documented ability to cause birth defects. The classification exists mainly to protect pharmacy staff, nurses, and other workers who compound or administer drugs daily and could absorb small amounts through skin contact or inhalation of dust over time.
This is an occupational safety designation, not a ban. Millions of people safely take fluconazole every year for yeast infections and other fungal conditions. But the hazardous label triggers workplace requirements for safe handling, including gloves and sometimes other protective equipment.
Liver Toxicity
Fluconazole can injure the liver, though the exact mechanism remains poorly understood. The most common presentation is a minor, temporary rise in liver enzymes, occurring in fewer than 5% of patients. In published case reports, however, the damage has occasionally been severe. Liver enzyme levels in those cases climbed anywhere from 1 to 96 times above normal baseline values. The average increase in one key marker (AST) was 27 times above baseline, and bilirubin levels averaged 9 times above normal.
What makes this particularly tricky is that the liver injury appears mostly unpredictable. It generally doesn’t follow a clear dose-dependent pattern, meaning a low dose can sometimes cause problems while a high dose may not. This idiosyncratic nature makes it difficult to predict who will be affected, which is why liver function monitoring is standard for patients taking fluconazole over extended periods.
Heart Rhythm Disruption
Fluconazole can lengthen the QT interval, which is the time it takes your heart’s lower chambers to contract and reset between beats. When that interval stretches too long, it creates an opening for a dangerous irregular rhythm called torsades de pointes, which can cause fainting, seizures, or sudden cardiac death.
Not everyone faces equal risk. The people most vulnerable to this effect include women, adults over 65, and anyone with existing heart disease, heart failure, or a family history of sudden cardiac death. Low potassium, calcium, or magnesium levels raise the danger further, as do impaired kidney or liver function, thyroid disease, and diabetes. The risk also compounds when fluconazole is taken alongside other medications that lengthen the QT interval, which is one reason its drug interactions matter so much.
Birth Defects and Pregnancy Risk
This is the primary reason fluconazole carries its hazardous classification. Case reports have documented a distinct pattern of birth defects in infants whose mothers took high doses (400 to 800 mg per day) during most or all of the first trimester. These defects include abnormal skull development, cleft palate, bowed thighbones, thin ribs, joint contractures, and congenital heart disease.
Even at the common single 150 mg dose used for vaginal yeast infections, the risk isn’t zero. A large population study published in The BMJ found that first-trimester fluconazole exposure was linked to a 30% increased risk of musculoskeletal malformations compared to women who used topical antifungal creams instead. That relative risk nearly doubled for cumulative doses above 450 mg. Epidemiological data also suggest a potential increase in spontaneous abortion, though controlled trials haven’t confirmed this.
The FDA label now states that fluconazole should be avoided during pregnancy except for severe or life-threatening fungal infections. Women of childbearing age taking high doses are advised to use effective contraception during treatment and for about one week afterward, since the drug lingers in the body for several days after the last dose.
Dangerous Drug Interactions
Fluconazole is a powerful inhibitor of the enzyme systems your liver uses to break down many other medications. Specifically, it strongly blocks one pathway (CYP2C19) and moderately blocks two others (CYP2C9 and CYP3A). When these pathways are suppressed, other drugs that rely on them for clearance build up to potentially toxic levels in your bloodstream.
The practical consequences are significant. Fluconazole can dangerously increase the blood-thinning effect of warfarin by slowing its breakdown, raising the risk of serious bleeding. It amplifies the sedative effects of certain benzodiazepines like midazolam and triazolam. It boosts levels of common acid-reflux medications like omeprazole and lansoprazole. And because many of the drugs affected by these enzyme pathways also carry their own QT-prolonging risks, the combination can compound the heart rhythm dangers described above. Anyone taking multiple medications needs careful review before adding fluconazole.
Kidney Clearance Problems
Fluconazole is eliminated almost entirely through the kidneys. When kidney function is reduced, the drug accumulates in the body and its toxic effects intensify. The FDA label specifies that patients with a creatinine clearance at or below 50 mL/min (roughly half of normal kidney function) should receive only 50% of the standard dose. Patients on regular dialysis receive a full dose but only after each dialysis session, which physically removes the drug from the blood. Without these adjustments, systemic toxicity from drug accumulation becomes a real concern.
Severe Skin Reactions
In rare cases, fluconazole triggers Stevens-Johnson syndrome or its more severe form, toxic epidermal necrolysis. These are serious immune reactions where the skin blisters and peels away from the body, requiring hospitalization. Published case reviews show that immunocompromised patients appear more susceptible. In documented cases, all patients required hospital care, though all eventually recovered completely. The reaction is uncommon enough that exact incidence rates are difficult to pin down, but its severity is why it appears on safety profiles.
The Bigger Picture: Antifungal Resistance
Beyond its direct toxicity, fluconazole plays a role in a growing public health threat. Candida auris, a fungal pathogen that spreads easily in healthcare facilities and causes life-threatening infections in already-sick patients, is frequently resistant to fluconazole and sometimes to multiple antifungal drug classes. The CDC tracked 6,304 clinical cases of C. auris in 2024 alone. Widespread fluconazole use, particularly in situations where it’s prescribed unnecessarily or for too long, contributes to the selective pressure that breeds resistant strains. This makes the drug hazardous not just to individuals but to the effectiveness of antifungal medicine broadly.